Breaking News
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
Protein linked with Alzheimer’s disease affects different brain cells differently

Protein linked with Alzheimer’s disease affects different brain cells differently

image_pdfDownload PDFimage_print

Amyloid beta, a protein linked with Alzheimer’s disease, has different properties in different cell types in the brains of fruit flies. This is the conclusion of a study led by researchers at Linköping University in Sweden. While amyloid beta is highly toxic for nerve cells, it seems that certain other types of cell are hardly damaged at all by aggregates of the protein.

The study, which has been published in Cell Chemical Biology, describes investigations by Swedish researchers into the sensitivity of different cells in the brain for one of the proteins closely associated with Alzheimer’s disease. In advanced Alzheimer’s disease, huge numbers of nerve cells in the brain are dead. Research has long been focused onto the process by which nerve cells are damaged by erroneously folded forms of the amyloid beta protein. These forms build up and eventually form plaques in the brain. But the erroneously folded forms of amyloid beta do not accumulate only in nerve cells. Amyloid deposits are also found in the blood vessels of the brain, in the retina, and in cells known as glial cells. The latter have various support functions in the brain, and it is unclear whether this plays a role in the development of disease. For this reason, the researchers wanted to investigate whether amyloid beta can form in these different types of cell, and whether it is toxic for other cells than nerve cells.

The researchers used fruit flies (Drosophila melanogaster) in their work. These have been extensively used in research to understand neuronal development and diseases, including Alzheimer’s disease. They used fruit flies that had been modified, such that their cells produced high levels of human amyloid beta 1-42, which is the more harmful of the two most common variants. The researchers could control which cells expressed the amyloid, and compared flies in which it was expressed in different cell types. The group had previously shown that the higher the amount of amyloid aggregate present in the nerve cells, the more severe was the disease in the flies.

“In this study we expressed the amyloid beta 1-42 in glial cells instead, and observed that huge amounts of aggregate accumulated around these cells. The flies, however, were hardly affected by the disease. They were affected to a certain degree, compared with control groups, but nowhere like as much as flies with amyloid beta in their nerve cells. This was a great surprise,” says Maria Jonson, research student in the Department of Physics, Chemistry and Biology and first author of the article.

The researchers wondered why amyloid did not harm the glial cells as much as nerve cells, and thus studied the structure of the aggregate in detail. Amyloid beta with faulty folding can be produced in various forms, and these are classified by, among other things, the degree of maturity. Mature amyloid appears in the microscope as thin, tightly packed strands, almost like a bundle of uncooked spaghetti. When immature, it looks more like cooked spaghetti, and forms tangles. Previous studies by the researchers in mice and humans have shown that both forms can be present, but this is the first time that neuron degradation was linked to the structure of the amyloid.

“We noted that glial cells seem to produce the mature, less harmful form of amyloid beta, while neurons cannot. The amyloid ends up outside the glial cells as bundles of fibers, while the same protein in its immature form gets stuck inside the neurons, and they die. This raises the question, of course, of the molecular mechanism that lies behind the high toxicity of amyloid beta for neurons, while glial cells can survive even with high levels, at least in fruit flies,” says Per Hammarström, professor in the Department of Physics, Chemistry and Biology, and leader of the study.

One important advantage of using fruit flies as experimental model, rather than mice, is that high levels of the amyloid beta aggregate in the flies leads to neurodegeneration and a considerably shorter lifetime, which is the same as in humans. Stefan Thor’s research group at the Department of Clinical and Experimental Medicine has developed the fruit flies used in the study.

Source:

https://liu.se/en/news-item/alzheimerplack-inte-lika-farligt-for-alla-celler-i-hjarnan

Tagged with:

About author

Related Articles